NWE Day-ahead Price Coupling Project Cost Issue

NWE Day-ahead price coupling project
Cost Issue
2
nd
 IG Meeting
26 October
APX ENDEX
Type and estimated amount of costs
Preliminary estimates of combined PX costs have been produced by APX
ENDEX
Based on NWE go live early 2013 using full PCR solution
To be reviewed with TSOs on Friday 28
th
 October
€10mil estimated cost, including contingency
Key assumptions
NWE PXs incur 60% of PCR common costs plus their own costs supporting PCR
APX ENDEX estimated own costs are representative of other PXs
Limited change to existing pre and post coupling arrangements (including
shipping) across NWE region
Limited change to existing contractual/regulatory arrangements across NWE
region
Phasing
PCR is completing design, and is entering implementation phase Q4/Q1
NWE design expected to be completed Q1; implementation start Q2
Main Cost Elements
PCR European
Solution (60% share
of common costs
plus individual NWE
PX contributions)
Local implementation
of PCR
NWE End-to-End
Technical Solution
NWE Contractual
Solution
Drafting, negotiation, modification of enduring agreements
TSO adapter software
Shipping solution software
Operational procedures design
Integration and procedural testing
Local hardware and communications infrastructure
Trading system interfaces
Algorithm development (c. 30%)
- starting point; prototype development
- procure industrial version
- build/test industrial algorithm
System development (c. 40%)
- design, specify systems
- procure system provider
- build/test systems
Joint PX contracts (c. 10%)
PCR project management, contingency (c. 20%)
Timing of Cost Commitments
Cost Sharing - PCR
PCR Common Costs
Jointly managed/procured costs (e.g., project manager, workstream leaders,
procurement manager, algorithm developer, system contractors, specific tasks)
Shared equally between 5 lead PCR exchanges (in effect, 60% incurred by NWE
PXs)
PCR Individual PX Costs
PX costs incurred supporting PCR European solution deliverables
Not shared between PXs
PCR Local PCR Implementation Costs
Costs incurred by each PC installing PCR systems and interfaces to local trading
systems
Not shared between PXs
New parties joining PCR
PCR open to new PXs: fair share of prior PCR investment (could be linked to
market size, and option to be full party or not)
Slide Note
Embed
Share

Preliminary estimates of the combined PX costs for the NWE Day-ahead Price Coupling project are provided, including key assumptions, main cost elements, timing of cost commitments, and cost sharing details. The project involves the design and implementation of the PCR solution, with cost distribution among the involved parties outlined.

  • Project Cost
  • Price Coupling
  • Energy Market
  • Implementation
  • Cost Sharing

Uploaded on Sep 26, 2024 | 0 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.

E N D

Presentation Transcript


  1. NWE Day-ahead price coupling project Cost Issue 2ndIG Meeting 26 October APX ENDEX

  2. Type and estimated amount of costs Preliminary estimates of combined PX costs have been produced by APX ENDEX Based on NWE go live early 2013 using full PCR solution To be reviewed with TSOs on Friday 28thOctober 10mil estimated cost, including contingency Key assumptions NWE PXs incur 60% of PCR common costs plus their own costs supporting PCR APX ENDEX estimated own costs are representative of other PXs Limited change to existing pre and post coupling arrangements (including shipping) across NWE region Limited change to existing contractual/regulatory arrangements across NWE region Phasing PCR is completing design, and is entering implementation phase Q4/Q1 NWE design expected to be completed Q1; implementation start Q2

  3. Main Cost Elements NWE Contractual Solution 0.4 Drafting, negotiation, modification of enduring agreements TSO adapter software Shipping solution software Operational procedures design Integration and procedural testing NWE End-to-End Technical Solution 2.3 Local hardware and communications infrastructure Trading system interfaces Local implementation of PCR 0.9 Algorithm development (c. 30%) - starting point; prototype development - procure industrial version - build/test industrial algorithm System development (c. 40%) - design, specify systems - procure system provider - build/test systems Joint PX contracts (c. 10%) PCR project management, contingency (c. 20%) PCR European Solution (60% share of common costs plus individual NWE PX contributions) 6.5

  4. Timing of Cost Commitments 3000 NWE contracts - implementation 2500 NWE contracts - design 2000 NWE technical - implementation 1500 NWE technical - design 1000 Local PCR implementation 500 PCR European solution - implementation 0 PCR European solution - design Pre Q4 2011 Q4 2011 Q1 2012 Q2 2012 Q3 2012 Q4 2012 Q1 2013

  5. Cost Sharing - PCR PCR Common Costs Jointly managed/procured costs (e.g., project manager, workstream leaders, procurement manager, algorithm developer, system contractors, specific tasks) Shared equally between 5 lead PCR exchanges (in effect, 60% incurred by NWE PXs) PCR Individual PX Costs PX costs incurred supporting PCR European solution deliverables Not shared between PXs PCR Local PCR Implementation Costs Costs incurred by each PC installing PCR systems and interfaces to local trading systems Not shared between PXs New parties joining PCR PCR open to new PXs: fair share of prior PCR investment (could be linked to market size, and option to be full party or not)

More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#